Frequencies for first 10,000 rows of indi_pt variable in indi2005q3 dataset : 'Preferred Term'-level medical | terminology describing the Indication | for use | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABDOMINAL ADHESIONS | 1 0.01 0.01 ABDOMINAL DISTENSION | 4 0.04 0.05 ABDOMINAL PAIN | 13 0.13 0.18 ABDOMINAL PAIN UPPER | 6 0.06 0.24 ABNORMAL BEHAVIOUR | 4 0.04 0.28 ABNORMAL LABOUR | 1 0.01 0.29 ABORTION | 2 0.02 0.31 ABORTION INDUCED | 5 0.05 0.36 ACCIDENTAL EXPOSURE | 2 0.02 0.38 ACCIDENTAL OVERDOSE | 2 0.02 0.40 ACIDOSIS | 1 0.01 0.41 ACNE | 51 0.51 0.92 ACNE CYSTIC | 3 0.03 0.95 ACQUIRED IMMUNODEFICIENCY SYNDROME | 26 0.26 1.21 ACROMEGALY | 4 0.04 1.25 ACTINIC KERATOSIS | 2 0.02 1.27 ACUTE LEUKAEMIA | 1 0.01 1.28 ACUTE LYMPHOCYTIC LEUKAEMIA | 40 0.40 1.68 ACUTE MYELOID LEUKAEMIA | 28 0.28 1.96 ACUTE MYOCARDIAL INFARCTION | 5 0.05 2.01 ACUTE PROMYELOCYTIC LEUKAEMIA | 1 0.01 2.02 ACUTE SINUSITIS | 3 0.03 2.05 ACUTE TONSILLITIS | 1 0.01 2.06 ADENOCARCINOMA | 1 0.01 2.07 ADENOCARCINOMA OF THE CERVIX | 3 0.03 2.10 ADENOCARCINOMA PANCREAS | 2 0.02 2.12 ADENOMA BENIGN | 1 0.01 2.13 ADENOMYOSIS | 1 0.01 2.14 ADENOSQUAMOUS CELL LUNG CANCER | 2 0.02 2.16 ADHESION | 1 0.01 2.17 ADVERSE EVENT | 9 0.09 2.26 AESTHESIONEUROBLASTOMA | 3 0.03 2.29 AFFECTIVE DISORDER | 9 0.09 2.38 AGGRESSION | 3 0.03 2.41 AGITATION | 14 0.14 2.55 AGORAPHOBIA | 2 0.02 2.57 ALCOHOL DETOXIFICATION | 2 0.02 2.59 ALCOHOLISM | 2 0.02 2.61 ALLERGIC BRONCHITIS | 1 0.01 2.62 ALLERGIC COUGH | 1 0.01 2.63 ALLOGENIC BONE MARROW TRANSPLANTATION.. | 4 0.04 2.67 ALOPECIA | 9 0.09 2.76 AMENORRHOEA | 2 0.02 2.78 AMNESIA | 1 0.01 2.79 ANAEMIA | 26 0.26 3.05 ANAEMIA OF MALIGNANT DISEASE | 7 0.07 3.12 ANAESTHESIA | 26 0.26 3.38 ANAESTHETIC COMPLICATION | 1 0.01 3.39 ANALGESIC EFFECT | 10 0.10 3.49 ANALGESIC THERAPY | 1 0.01 3.50 ANAPHYLACTIC REACTION | 2 0.02 3.52 ANAPLASTIC ASTROCYTOMA | 1 0.01 3.53 ANDROGEN DEFICIENCY | 1 0.01 3.54 ANGER | 3 0.03 3.57 ANGINA PECTORIS | 20 0.20 3.77 ANGINA UNSTABLE | 1 0.01 3.78 ANGIOGRAM | 3 0.03 3.81 ANGIONEUROTIC OEDEMA | 2 0.02 3.83 ANGIOPLASTY | 1 0.01 3.84 ANKYLOSING SPONDYLITIS | 11 0.11 3.95 ANOREXIA | 1 0.01 3.96 ANOREXIA NERVOSA | 1 0.01 3.97 ANOVULATORY CYCLE | 1 0.01 3.98 ANTIBIOTIC LEVEL | 10 0.10 4.08 ANTIBIOTIC PROPHYLAXIS | 8 0.08 4.16 ANTICOAGULANT THERAPY | 11 0.11 4.27 ANTIDEPRESSANT THERAPY | 3 0.03 4.30 ANTIEMETIC SUPPORTIVE CARE | 4 0.04 4.34 ANTIFUNGAL PROPHYLAXIS | 3 0.03 4.37 ANTIPHOSPHOLIPID SYNDROME | 1 0.01 4.38 ANTIPYRESIS | 1 0.01 4.39 ANTIVIRAL PROPHYLAXIS | 20 0.20 4.59 ANXIETY | 96 0.96 5.55 ANXIETY DISORDER | 3 0.03 5.58 AORTIC ANEURYSM RUPTURE | 1 0.01 5.59 AORTIC BYPASS | 1 0.01 5.60 AORTIC VALVE REPLACEMENT | 1 0.01 5.61 APHTHOUS STOMATITIS | 1 0.01 5.62 APLASTIC ANAEMIA | 1 0.01 5.63 APPENDICITIS | 1 0.01 5.64 APPETITE DISORDER | 1 0.01 5.65 ARRHYTHMIA | 11 0.11 5.76 ARTERIAL BYPASS OPERATION | 2 0.02 5.78 ARTERIAL THROMBOSIS | 1 0.01 5.79 ARTERIOGRAM CORONARY | 1 0.01 5.80 ARTERIOGRAM RENAL | 2 0.02 5.82 ARTERIOSCLEROSIS | 1 0.01 5.83 ARTHRALGIA | 52 0.52 6.35 ARTHRITIS | 89 0.89 7.24 ARTHROPATHY | 5 0.05 7.29 ARTHROPOD BITE | 2 0.02 7.31 ARTHROSCOPY | 1 0.01 7.32 ASPERGILLOSIS | 3 0.03 7.35 ASTHENIA | 1 0.01 7.36 ASTHMA | 90 0.90 8.26 ASTROCYTOMA | 1 0.01 8.27 ATHEROSCLEROSIS | 1 0.01 8.28 ATHEROSCLEROSIS OBLITERANS | 1 0.01 8.29 ATRIAL FIBRILLATION | 71 0.71 9.00 ATRIAL FLUTTER | 4 0.04 9.04 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 40 0.40 9.44 AUTISM | 5 0.05 9.49 AUTOIMMUNE DISORDER | 1 0.01 9.50 AUTOIMMUNE HEPATITIS | 2 0.02 9.52 AUTOIMMUNE THYROIDITIS | 1 0.01 9.53 B-CELL LYMPHOMA | 8 0.08 9.61 BACK DISORDER | 2 0.02 9.63 BACK INJURY | 3 0.03 9.66 BACK PAIN | 70 0.70 10.36 BACTERIAL INFECTION | 8 0.08 10.44 BARRETT'S OESOPHAGUS | 2 0.02 10.46 BEHCET'S SYNDROME | 1 0.01 10.47 BENIGN HYDATIDIFORM MOLE | 2 0.02 10.49 BENIGN PROSTATIC HYPERPLASIA | 23 0.23 10.72 BILIARY CIRRHOSIS PRIMARY | 1 0.01 10.73 BILIARY TRACT DISORDER | 1 0.01 10.74 BIOPSY | 1 0.01 10.75 BIPOLAR DISORDER | 76 0.76 11.51 BIPOLAR I DISORDER | 6 0.06 11.57 BK VIRUS INFECTION | 1 0.01 11.58 BLADDER CANCER | 5 0.05 11.63 BLADDER CANCER STAGE III | 2 0.02 11.65 BLADDER DISORDER | 3 0.03 11.68 BLEPHAROSPASM | 2 0.02 11.70 BLISTER | 1 0.01 11.71 BLOOD CHOLESTEROL | 12 0.12 11.83 BLOOD CHOLESTEROL INCREASED | 84 0.84 12.67 BLOOD DISORDER | 2 0.02 12.69 BLOOD GLUCOSE ABNORMAL | 4 0.04 12.73 BLOOD GLUCOSE INCREASED | 3 0.03 12.76 BLOOD PH DECREASED | 1 0.01 12.77 BLOOD PHOSPHORUS INCREASED | 1 0.01 12.78 BLOOD PRESSURE | 24 0.24 13.02 BLOOD PRESSURE DECREASED | 2 0.02 13.04 BLOOD PRESSURE INCREASED | 6 0.06 13.10 BLOOD PRESSURE MANAGEMENT | 1 0.01 13.11 BLOOD PRESSURE SYSTOLIC | 3 0.03 13.14 BLOOD PROLACTIN INCREASED | 2 0.02 13.16 BLOOD TESTOSTERONE DECREASED | 1 0.01 13.17 BLOOD TRIGLYCERIDES INCREASED | 2 0.02 13.19 BLOOD URIC ACID INCREASED | 1 0.01 13.20 BODY HEIGHT BELOW NORMAL | 2 0.02 13.22 BONE CANCER METASTATIC | 2 0.02 13.24 BONE DENSITY DECREASED | 2 0.02 13.26 BONE DISORDER | 4 0.04 13.30 BONE MARROW CONDITIONING REGIMEN | 3 0.03 13.33 BONE MARROW LEUKAEMIC CELL INFILTRATION | 3 0.03 13.36 BONE MARROW TRANSPLANT | 12 0.12 13.48 BONE MARROW TUMOUR CELL INFILTRATION | 2 0.02 13.50 BONE NEOPLASM MALIGNANT | 1 0.01 13.51 BONE PAIN | 2 0.02 13.53 BONE SARCOMA | 7 0.07 13.60 BONE SCAN | 1 0.01 13.61 BRAIN CONTUSION | 1 0.01 13.62 BRAIN NEOPLASM | 1 0.01 13.63 BREAST CANCER | 98 0.98 14.61 BREAST CANCER FEMALE | 5 0.05 14.66 BREAST CANCER IN SITU | 3 0.03 14.69 BREAST CANCER METASTATIC | 39 0.39 15.08 BREAST CANCER RECURRENT | 1 0.01 15.09 BREAST CANCER STAGE I | 1 0.01 15.10 BREAST CANCER STAGE IV | 1 0.01 15.11 BRONCHIAL CARCINOMA | 1 0.01 15.12 BRONCHIOLITIS | 1 0.01 15.13 BRONCHITIS | 17 0.17 15.30 BRONCHITIS ACUTE | 3 0.03 15.33 BRONCHITIS CHRONIC | 5 0.05 15.38 BRONCHOPNEUMONIA | 2 0.02 15.40 BRONCHOPNEUMOPATHY | 1 0.01 15.41 BRONCHOSPASM | 1 0.01 15.42 BURKITT'S LYMPHOMA | 2 0.02 15.44 CALCULUS URETERIC | 1 0.01 15.45 CANCER PAIN | 27 0.27 15.72 CANDIDA PNEUMONIA | 2 0.02 15.74 CANDIDIASIS | 1 0.01 15.75 CARCINOID SYNDROME | 1 0.01 15.76 CARCINOID TUMOUR | 1 0.01 15.77 CARCINOID TUMOUR OF THE SMALL BOWEL | 3 0.03 15.80 CARDIAC DISORDER | 6 0.06 15.86 CARDIAC FAILURE | 26 0.26 16.12 CARDIAC FAILURE CHRONIC | 10 0.10 16.22 CARDIAC FAILURE CONGESTIVE | 17 0.17 16.39 CARDIAC STRESS TEST | 4 0.04 16.43 CARDIO-RESPIRATORY ARREST | 3 0.03 16.46 CARDIOMYOPATHY | 2 0.02 16.48 CARDIOVASCULAR DISORDER | 7 0.07 16.55 CAROTID ARTERY STENOSIS | 1 0.01 16.56 CARPAL TUNNEL SYNDROME | 4 0.04 16.60 CATAPLEXY | 1 0.01 16.61 CATARACT | 2 0.02 16.63 CATARACT OPERATION | 3 0.03 16.66 CATHETER PLACEMENT | 2 0.02 16.68 CATHETER RELATED INFECTION | 2 0.02 16.70 CAUDA EQUINA SYNDROME | 1 0.01 16.71 CELLULITIS | 4 0.04 16.75 CELLULITIS ORBITAL | 1 0.01 16.76 CENTRAL NERVOUS SYSTEM LYMPHOMA | 4 0.04 16.80 CEREBRAL HAEMORRHAGE | 1 0.01 16.81 CEREBRAL INFARCTION | 16 0.16 16.97 CEREBROVASCULAR ACCIDENT | 4 0.04 17.01 CEREBROVASCULAR ACCIDENT PROPHYLAXIS | 30 0.30 17.31 CERUMEN IMPACTION | 1 0.01 17.32 CERVICOBRACHIAL SYNDROME | 1 0.01 17.33 CERVIX DISORDER | 1 0.01 17.34 CHEMOTHERAPY | 26 0.26 17.60 CHEST WALL PAIN | 1 0.01 17.61 CHLAMYDIAL INFECTION | 1 0.01 17.62 CHOLELITHIASIS | 2 0.02 17.64 CHOROID MELANOMA | 4 0.04 17.68 CHOROIDAL NEOVASCULARISATION | 1 0.01 17.69 CHOROIDITIS | 1 0.01 17.70 CHRONIC FATIGUE SYNDROME | 1 0.01 17.71 CHRONIC INFLAMMATORY DEMYELINATING PO.. | 1 0.01 17.72 CHRONIC LYMPHOCYTIC LEUKAEMIA | 29 0.29 18.01 CHRONIC LYMPHOCYTIC LEUKAEMIA STAGE 2 | 1 0.01 18.02 CHRONIC LYMPHOCYTIC LEUKAEMIA STAGE 4 | 2 0.02 18.04 CHRONIC MYELOID LEUKAEMIA | 24 0.24 18.28 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 33 0.33 18.61 CHRONIC SINUSITIS | 6 0.06 18.67 CIRCUMCISION | 1 0.01 18.68 CLOSED HEAD INJURY | 1 0.01 18.69 CLOSTRIDIAL INFECTION | 2 0.02 18.71 COAGULOPATHY | 1 0.01 18.72 COGNITIVE DISORDER | 4 0.04 18.76 COLITIS ULCERATIVE | 4 0.04 18.80 COLON CANCER | 28 0.28 19.08 COLON CANCER METASTATIC | 10 0.10 19.18 COLON CANCER STAGE III | 4 0.04 19.22 COLONOSCOPY | 4 0.04 19.26 COLORECTAL CANCER | 22 0.22 19.48 COLORECTAL CANCER METASTATIC | 45 0.45 19.93 COMPLETED SUICIDE | 1 0.01 19.94 COMPLEX PARTIAL SEIZURES | 3 0.03 19.97 COMPLEX REGIONAL PAIN SYNDROME | 4 0.04 20.01 COMPUTERISED TOMOGRAM | 30 0.30 20.31 COMPUTERISED TOMOGRAM ABDOMEN | 22 0.22 20.53 COMPUTERISED TOMOGRAM HEAD | 3 0.03 20.56 COMPUTERISED TOMOGRAM KIDNEY | 1 0.01 20.57 COMPUTERISED TOMOGRAM THORAX | 9 0.09 20.66 CONGENITAL NEPHROTIC SYNDROME | 1 0.01 20.67 CONGESTIVE CARDIOMYOPATHY | 2 0.02 20.69 CONJUNCTIVITIS INFECTIVE | 1 0.01 20.70 CONSTIPATION | 41 0.41 21.11 CONSTIPATION PROPHYLAXIS | 2 0.02 21.13 CONTRACEPTION | 38 0.38 21.51 CONVULSION | 35 0.35 21.86 CONVULSION PROPHYLAXIS | 2 0.02 21.88 CORD BLOOD TRANSPLANT THERAPY | 5 0.05 21.93 CORONARY ANGIOPLASTY | 1 0.01 21.94 CORONARY ARTERIAL STENT INSERTION | 2 0.02 21.96 CORONARY ARTERY DISEASE | 25 0.25 22.21 CORONARY ARTERY STENOSIS | 1 0.01 22.22 CORONARY ARTERY SURGERY | 2 0.02 22.24 COUGH | 18 0.18 22.42 CRANIOPHARYNGIOMA | 1 0.01 22.43 CROHN'S DISEASE | 75 0.75 23.18 CRYPTOCOCCOSIS | 1 0.01 23.19 CUTANEOUS SPOROTRICHOSIS | 1 0.01 23.20 CYSTITIS | 4 0.04 23.24 CYSTITIS INTERSTITIAL | 7 0.07 23.31 CYSTOSCOPY | 1 0.01 23.32 CYTOMEGALOVIRUS ENTERITIS | 1 0.01 23.33 CYTOMEGALOVIRUS INFECTION | 3 0.03 23.36 DECREASED APPETITE | 2 0.02 23.38 DEEP VEIN THROMBOSIS | 1 0.01 23.39 DEHYDRATION | 1 0.01 23.40 DELIRIUM | 5 0.05 23.45 DELUSION | 1 0.01 23.46 DEMENTIA | 11 0.11 23.57 DEMENTIA ALZHEIMER'S TYPE | 24 0.24 23.81 DEMYELINATING POLYNEUROPATHY | 1 0.01 23.82 DENTAL OPERATION | 1 0.01 23.83 DENTURE WEARER | 1 0.01 23.84 DEPRESSED MOOD | 1 0.01 23.85 DEPRESSION | 291 2.91 26.76 DERMATITIS | 2 0.02 26.78 DERMATITIS ALLERGIC | 1 0.01 26.79 DERMATITIS ATOPIC | 4 0.04 26.83 DERMATITIS INFECTED | 1 0.01 26.84 DERMATOMYOSITIS | 1 0.01 26.85 DEVICE RELATED INFECTION | 2 0.02 26.87 DIABETES MELLITUS | 139 1.39 28.26 DIABETES MELLITUS INSULIN-DEPENDENT | 18 0.18 28.44 DIABETES MELLITUS MANAGEMENT | 1 0.01 28.45 DIABETES MELLITUS NON-INSULIN-DEPENDENT | 41 0.41 28.86 DIABETIC FOOT | 1 0.01 28.87 DIABETIC NEPHROPATHY | 1 0.01 28.88 DIABETIC NEUROPATHY | 4 0.04 28.92 DIABETIC RETINAL OEDEMA | 2 0.02 28.94 DIAGNOSTIC PROCEDURE | 1 0.01 28.95 DIARRHOEA | 9 0.09 29.04 DIFFUSE LARGE B-CELL LYMPHOMA | 19 0.19 29.23 DIFFUSE PANBRONCHIOLITIS | 2 0.02 29.25 DISEASE RECURRENCE | 1 0.01 29.26 DISSEMINATED INTRAVASCULAR COAGULATION | 3 0.03 29.29 DISSOCIATIVE DISORDER | 1 0.01 29.30 DIURETIC EFFECT | 3 0.03 29.33 DIURETIC THERAPY | 2 0.02 29.35 DIVERTICULITIS | 1 0.01 29.36 DIZZINESS | 2 0.02 29.38 DRUG ABUSER | 1 0.01 29.39 DRUG DEPENDENCE | 6 0.06 29.45 DRUG DETOXIFICATION | 18 0.18 29.63 DRUG EXPOSURE DURING PREGNANCY | 18 0.18 29.81 DRUG INTOLERANCE | 1 0.01 29.82 DRUG RESISTANCE | 1 0.01 29.83 DRUG THERAPY | 2 0.02 29.85 DRUG TOXICITY | 2 0.02 29.87 DRUG USE FOR UNKNOWN INDICATION | 623 6.23 36.10 DRUG WITHDRAWAL SYNDROME | 2 0.02 36.12 DRY EYE | 2 0.02 36.14 DRY MOUTH | 1 0.01 36.15 DUODENAL ULCER | 8 0.08 36.23 DUODENITIS | 2 0.02 36.25 DYSAESTHESIA | 1 0.01 36.26 DYSCHEZIA | 3 0.03 36.29 DYSFUNCTIONAL UTERINE BLEEDING | 1 0.01 36.30 DYSKINESIA | 1 0.01 36.31 DYSLIPIDAEMIA | 12 0.12 36.43 DYSMENORRHOEA | 1 0.01 36.44 DYSPEPSIA | 4 0.04 36.48 DYSPNOEA | 14 0.14 36.62 DYSTHYMIC DISORDER | 6 0.06 36.68 DYSTONIA | 1 0.01 36.69 DYSURIA | 3 0.03 36.72 EAR INFECTION | 2 0.02 36.74 EAR PAIN | 1 0.01 36.75 EAR PRURITUS | 1 0.01 36.76 ECZEMA | 6 0.06 36.82 EJACULATION DISORDER | 1 0.01 36.83 ELECTROLYTE IMBALANCE | 1 0.01 36.84 EMOTIONAL DISTRESS | 1 0.01 36.85 EMPHYSEMA | 10 0.10 36.95 ENCEPHALITIS HERPES | 1 0.01 36.96 ENDOCARDITIS | 4 0.04 37.00 ENDOMETRIAL CANCER | 3 0.03 37.03 ENDOMETRIOSIS | 3 0.03 37.06 ENDOSCOPY | 2 0.02 37.08 ENTEROCOCCAL INFECTION | 1 0.01 37.09 EOSINOPHILIC MYOCARDITIS | 4 0.04 37.13 EPIDIDYMITIS | 1 0.01 37.14 EPIDURAL ANAESTHESIA | 7 0.07 37.21 EPIGLOTTIC CARCINOMA | 1 0.01 37.22 EPILEPSY | 62 0.62 37.84 ERECTILE DYSFUNCTION | 35 0.35 38.19 ESCHERICHIA INFECTION | 2 0.02 38.21 ESSENTIAL HYPERTENSION | 27 0.27 38.48 ESSENTIAL THROMBOCYTHAEMIA | 1 0.01 38.49 EUPHORIC MOOD | 2 0.02 38.51 EWING'S SARCOMA | 4 0.04 38.55 EX-SMOKER | 1 0.01 38.56 EYE INFLAMMATION | 1 0.01 38.57 EYE IRRITATION | 2 0.02 38.59 EYE PAIN | 1 0.01 38.60 FABRY'S DISEASE | 11 0.11 38.71 FACIAL PAIN | 2 0.02 38.73 FACTOR IX DEFICIENCY | 2 0.02 38.75 FACTOR VII DEFICIENCY | 1 0.01 38.76 FACTOR VIII DEFICIENCY | 2 0.02 38.78 FAMILIAL TREMOR | 1 0.01 38.79 FATIGUE | 1 0.01 38.80 FEBRILE INFECTION | 1 0.01 38.81 FEBRILE NEUTROPENIA | 7 0.07 38.88 FEELING COLD | 1 0.01 38.89 FIBROMYALGIA | 10 0.10 38.99 FLUID OVERLOAD | 1 0.01 39.00 FLUID REPLACEMENT | 1 0.01 39.01 FLUID RETENTION | 1 0.01 39.02 FOETAL GROWTH RETARDATION | 1 0.01 39.03 FORMICATION | 2 0.02 39.05 FRACTURE | 1 0.01 39.06 FUNGAL INFECTION | 8 0.08 39.14 GANGRENE | 1 0.01 39.15 GASTRIC CANCER | 12 0.12 39.27 GASTRIC DISORDER | 2 0.02 39.29 GASTRIC ULCER | 20 0.20 39.49 GASTRIC ULCER HAEMORRHAGE | 5 0.05 39.54 GASTRITIS | 29 0.29 39.83 GASTRITIS EROSIVE | 1 0.01 39.84 GASTROENTERITIS | 2 0.02 39.86 GASTROINTESTINAL DISORDER | 6 0.06 39.92 GASTROINTESTINAL DISORDER THERAPY | 1 0.01 39.93 GASTROINTESTINAL HAEMORRHAGE | 1 0.01 39.94 GASTROINTESTINAL INFLAMMATION | 1 0.01 39.95 GASTROINTESTINAL STROMAL TUMOUR | 3 0.03 39.98 GASTROOESOPHAGEAL REFLUX DISEASE | 30 0.30 40.28 GAUCHER'S DISEASE | 10 0.10 40.38 GENERAL ANAESTHESIA | 3 0.03 40.41 GENERALISED ANXIETY DISORDER | 5 0.05 40.46 GENITOURINARY TRACT INFECTION | 1 0.01 40.47 GINGIVITIS | 1 0.01 40.48 GLAUCOMA | 16 0.16 40.64 GLIOBLASTOMA MULTIFORME | 13 0.13 40.77 GLOMERULONEPHRITIS CHRONIC | 1 0.01 40.78 GLOMERULONEPHRITIS PROLIFERATIVE | 5 0.05 40.83 GLUCOSE TOLERANCE IMPAIRED | 1 0.01 40.84 GOUT | 6 0.06 40.90 GOUTY ARTHRITIS | 1 0.01 40.91 GRAFT VERSUS HOST DISEASE | 5 0.05 40.96 GRAND MAL CONVULSION | 2 0.02 40.98 GROWTH HORMONE DEFICIENCY | 11 0.11 41.09 GROWTH RETARDATION | 2 0.02 41.11 GUILLAIN-BARRE SYNDROME | 2 0.02 41.13 GYNAECOMASTIA | 2 0.02 41.15 HAEMODIALYSIS | 3 0.03 41.18 HAEMOGLOBIN DECREASED | 1 0.01 41.19 HAEMOPHILIA | 4 0.04 41.23 HAEMORRHAGE | 16 0.16 41.39 HALLUCINATION | 1 0.01 41.40 HEAD INJURY | 1 0.01 41.41 HEADACHE | 25 0.25 41.66 HEART DISEASE CONGENITAL | 2 0.02 41.68 HEART RATE IRREGULAR | 1 0.01 41.69 HEART TRANSPLANT | 5 0.05 41.74 HEART VALVE REPLACEMENT | 2 0.02 41.76 HELICOBACTER INFECTION | 12 0.12 41.88 HEPATIC CIRRHOSIS | 3 0.03 41.91 HEPATIC NEOPLASM | 1 0.01 41.92 HEPATIC NEOPLASM MALIGNANT | 6 0.06 41.98 HEPATITIS | 2 0.02 42.00 HEPATITIS B | 4 0.04 42.04 HEPATITIS C | 130 1.30 43.34 HEPATITIS C VIRUS | 4 0.04 43.38 HERPES SIMPLEX | 5 0.05 43.43 HERPES ZOSTER | 21 0.21 43.64 HIATUS HERNIA | 2 0.02 43.66 HIRSUTISM | 2 0.02 43.68 HISTOPLASMOSIS | 2 0.02 43.70 HIV INFECTION | 269 2.69 46.39 HIV TEST POSITIVE | 11 0.11 46.50 HIV WASTING SYNDROME | 1 0.01 46.51 HODGKIN'S DISEASE | 10 0.10 46.61 HORMONE REPLACEMENT THERAPY | 104 1.04 47.65 HOT FLUSH | 3 0.03 47.68 HOUSE DUST ALLERGY | 1 0.01 47.69 HYPERALDOSTERONISM | 1 0.01 47.70 HYPERCALCAEMIA | 3 0.03 47.73 HYPERCALCAEMIA OF MALIGNANCY | 1 0.01 47.74 HYPERCHOLESTEROLAEMIA | 83 0.83 48.57 HYPEREOSINOPHILIC SYNDROME | 2 0.02 48.59 HYPERHIDROSIS | 1 0.01 48.60 HYPERKALAEMIA | 4 0.04 48.64 HYPERLIPIDAEMIA | 48 0.48 49.12 HYPERPARATHYROIDISM PRIMARY | 2 0.02 49.14 HYPERPARATHYROIDISM SECONDARY | 26 0.26 49.40 HYPERPHOSPHATAEMIA | 21 0.21 49.61 HYPERSENSITIVITY | 12 0.12 49.73 HYPERSOMNIA | 1 0.01 49.74 HYPERTENSION | 363 3.63 53.37 HYPERTENSIVE NEPHROPATHY | 2 0.02 53.39 HYPERTHYROIDISM | 7 0.07 53.46 HYPERTONIC BLADDER | 11 0.11 53.57 HYPERTRIGLYCERIDAEMIA | 3 0.03 53.60 HYPERURICAEMIA | 11 0.11 53.71 HYPERVENTILATION | 2 0.02 53.73 HYPOCALCAEMIA | 1 0.01 53.74 HYPOGAMMAGLOBULINAEMIA | 8 0.08 53.82 HYPOGONADISM | 1 0.01 53.83 HYPOKALAEMIA | 3 0.03 53.86 HYPOPITUITARISM | 4 0.04 53.90 HYPOTENSION | 4 0.04 53.94 HYPOTHYROIDISM | 26 0.26 54.20 HYPOTONIA | 1 0.01 54.21 HYPOTRICHOSIS | 2 0.02 54.23 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 1 0.01 54.24 ILL-DEFINED DISORDER | 338 3.38 57.62 IMMUNOBLASTIC LYMPHOMA | 6 0.06 57.68 IMMUNODEFICIENCY | 1 0.01 57.69 IMMUNOSUPPRESSANT DRUG THERAPY | 3 0.03 57.72 IMMUNOSUPPRESSION | 11 0.11 57.83 INCONTINENCE | 7 0.07 57.90 INDUCTION OF ANAESTHESIA | 6 0.06 57.96 INFECTION | 24 0.24 58.20 INFECTION PROPHYLAXIS | 30 0.30 58.50 INFERTILITY MALE | 1 0.01 58.51 INFILTRATION ANAESTHESIA | 1 0.01 58.52 INFLAMMATION | 15 0.15 58.67 INFLAMMATORY BOWEL DISEASE | 1 0.01 58.68 INFLUENZA | 6 0.06 58.74 INJURY | 1 0.01 58.75 INSOMNIA | 66 0.66 59.41 INSULIN-REQUIRING TYPE II DIABETES ME.. | 14 0.14 59.55 INTENTIONAL MISUSE | 1 0.01 59.56 INTENTIONAL SELF-INJURY | 1 0.01 59.57 INTERCOSTAL NEURALGIA | 1 0.01 59.58 INTERMITTENT CLAUDICATION | 1 0.01 59.59 INTERSTITIAL LUNG DISEASE | 5 0.05 59.64 INTERVERTEBRAL DISC DISORDER | 1 0.01 59.65 INTERVERTEBRAL DISC PROTRUSION | 4 0.04 59.69 INTRAOCULAR PRESSURE INCREASED | 4 0.04 59.73 INTRAOCULAR PRESSURE TEST | 1 0.01 59.74 INTUBATION | 1 0.01 59.75 IRON DEFICIENCY | 1 0.01 59.76 IRON DEFICIENCY ANAEMIA | 1 0.01 59.77 IRRITABILITY | 1 0.01 59.78 IRRITABLE BOWEL SYNDROME | 7 0.07 59.85 ISCHAEMIC STROKE | 1 0.01 59.86 JOINT DISLOCATION | 3 0.03 59.89 JOINT INJURY | 3 0.03 59.92 JOINT SWELLING | 1 0.01 59.93 JUVENILE ARTHRITIS | 6 0.06 59.99 KAPOSI'S SARCOMA | 1 0.01 60.00 KAWASAKI'S DISEASE | 2 0.02 60.02 KELOID SCAR | 1 0.01 60.03 KERATITIS | 1 0.01 60.04 KERATITIS HERPETIC | 4 0.04 60.08 KLEBSIELLA INFECTION | 1 0.01 60.09 LABOUR INDUCTION | 1 0.01 60.10 LACRIMATION INCREASED | 1 0.01 60.11 LARGE CELL CARCINOMA OF THE RESPIRATO.. | 1 0.01 60.12 LARYNGEAL STENOSIS | 1 0.01 60.13 LARYNGOPHARYNGITIS | 2 0.02 60.15 LARYNGOTRACHEITIS | 1 0.01 60.16 LEFT VENTRICULAR FAILURE | 1 0.01 60.17 LEG AMPUTATION | 1 0.01 60.18 LEIOMYOSARCOMA | 3 0.03 60.21 LEUKAEMIA | 5 0.05 60.26 LEUKAEMIA RECURRENT | 1 0.01 60.27 LICE INFESTATION | 6 0.06 60.33 LIMB INJURY | 1 0.01 60.34 LIP AND/OR ORAL CAVITY CANCER | 3 0.03 60.37 LIPID METABOLISM DISORDER | 1 0.01 60.38 LIPIDS INCREASED | 1 0.01 60.39 LIVER DISORDER | 1 0.01 60.40 LIVER TRANSPLANT | 16 0.16 60.56 LOCAL ANAESTHESIA | 5 0.05 60.61 LOCAL ANTIFUNGAL TREATMENT | 3 0.03 60.64 LOW DENSITY LIPOPROTEIN INCREASED | 2 0.02 60.66 LOWER RESPIRATORY TRACT INFECTION | 3 0.03 60.69 LUMBAR SPINAL STENOSIS | 1 0.01 60.70 LUNG ADENOCARCINOMA | 8 0.08 60.78 LUNG ADENOCARCINOMA RECURRENT | 1 0.01 60.79 LUNG ADENOCARCINOMA STAGE IV | 1 0.01 60.80 LUNG CANCER METASTATIC | 6 0.06 60.86 LUNG CARCINOMA CELL TYPE UNSPECIFIED .. | 1 0.01 60.87 LUNG DISORDER | 8 0.08 60.95 LUNG INFECTION | 1 0.01 60.96 LUNG NEOPLASM MALIGNANT | 13 0.13 61.09 LUNG SQUAMOUS CELL CARCINOMA STAGE UN.. | 1 0.01 61.10 LUNG TRANSPLANT | 11 0.11 61.21 LUNG TRANSPLANT REJECTION | 1 0.01 61.22 LUTEAL PHASE DEFICIENCY | 1 0.01 61.23 LYMPHADENOPATHY | 1 0.01 61.24 LYMPHOMA | 25 0.25 61.49 MACULAR DEGENERATION | 5 0.05 61.54 MAINTENANCE OF ANAESTHESIA | 4 0.04 61.58 MAJOR DEPRESSION | 11 0.11 61.69 MALAISE | 2 0.02 61.71 MALARIA PROPHYLAXIS | 3 0.03 61.74 MALE PATTERN BALDNESS | 2 0.02 61.76 MALIGNANT HISTIOCYTOSIS | 1 0.01 61.77 MALIGNANT MELANOMA | 7 0.07 61.84 MALIGNANT MESENCHYMOMA | 6 0.06 61.90 MALIGNANT NEOPLASM OF RENAL PELVIS | 1 0.01 61.91 MALIGNANT NEOPLASM PROGRESSION | 5 0.05 61.96 MANIA | 4 0.04 62.00 MANTLE CELL LYMPHOMA | 10 0.10 62.10 MEDIASTINITIS | 3 0.03 62.13 MEDICAL DIET | 4 0.04 62.17 MEDICATION DILUTION | 2 0.02 62.19 MEDICATION ERROR | 2 0.02 62.21 MENIERE'S DISEASE | 1 0.01 62.22 MENINGITIS | 5 0.05 62.27 MENOPAUSAL SYMPTOMS | 12 0.12 62.39 MENOPAUSE | 4 0.04 62.43 MENORRHAGIA | 5 0.05 62.48 MESENTERIC VEIN THROMBOSIS | 2 0.02 62.50 MESOTHELIOMA | 4 0.04 62.54 METABOLIC DISORDER | 1 0.01 62.55 METABOLIC SYNDROME | 1 0.01 62.56 METASTASES TO BONE | 63 0.63 63.19 METASTASES TO CENTRAL NERVOUS SYSTEM | 7 0.07 63.26 METASTASES TO LIVER | 6 0.06 63.32 METASTASIS | 8 0.08 63.40 METASTATIC MALIGNANT MELANOMA | 10 0.10 63.50 METASTATIC NEOPLASM | 5 0.05 63.55 METASTATIC RENAL CELL CARCINOMA | 5 0.05 63.60 METASTATIC SQUAMOUS CELL CARCINOMA | 3 0.03 63.63 MICROALBUMINURIA | 1 0.01 63.64 MICROSCOPIC POLYANGIITIS | 2 0.02 63.66 MICTURITION URGENCY | 1 0.01 63.67 MIGRAINE | 29 0.29 63.96 MIGRAINE PROPHYLAXIS | 2 0.02 63.98 MINERAL SUPPLEMENTATION | 2 0.02 64.00 MIXED HYPERLIPIDAEMIA | 2 0.02 64.02 MONARTHRITIS | 7 0.07 64.09 MOOD ALTERED | 1 0.01 64.10 MOOD DISORDER DUE TO A GENERAL MEDICA.. | 1 0.01 64.11 MOOD SWINGS | 5 0.05 64.16 MOTION SICKNESS | 1 0.01 64.17 MUCOPOLYSACCHARIDOSIS I | 2 0.02 64.19 MULTI-ORGAN FAILURE | 1 0.01 64.20 MULTIPLE ALLERGIES | 7 0.07 64.27 MULTIPLE FRACTURES | 1 0.01 64.28 MULTIPLE MYELOMA | 94 0.94 65.22 MULTIPLE SCLEROSIS | 532 5.32 70.54 MULTIPLE SYSTEM ATROPHY | 3 0.03 70.57 MULTIPLE-DRUG RESISTANCE | 1 0.01 70.58 MUSCLE DISORDER | 2 0.02 70.60 MUSCLE RELAXANT THERAPY | 1 0.01 70.61 MUSCLE RIGIDITY | 3 0.03 70.64 MUSCLE SPASMS | 10 0.10 70.74 MUSCLE SPASTICITY | 9 0.09 70.83 MUSCLE STRAIN | 1 0.01 70.84 MUSCULOSKELETAL PAIN | 3 0.03 70.87 MUSCULOSKELETAL STIFFNESS | 1 0.01 70.88 MYALGIA | 9 0.09 70.97 MYCOBACTERIUM AVIUM COMPLEX INFECTION | 2 0.02 70.99 MYCOBACTERIUM MARINUM INFECTION | 1 0.01 71.00 MYCOPLASMA INFECTION | 1 0.01 71.01 MYCOSIS FUNGOIDES | 3 0.03 71.04 MYELODYSPLASTIC SYNDROME | 6 0.06 71.10 MYELOID LEUKAEMIA | 2 0.02 71.12 MYELOPROLIFERATIVE DISORDER | 1 0.01 71.13 MYOCARDIAL INFARCTION | 22 0.22 71.35 MYOCARDIAL ISCHAEMIA | 18 0.18 71.53 MYOCARDITIS | 3 0.03 71.56 MYOCLONUS | 1 0.01 71.57 MYOFASCIAL PAIN SYNDROME | 1 0.01 71.58 MYOTONIA | 1 0.01 71.59 NAIL TINEA | 10 0.10 71.69 NARCOLEPSY | 4 0.04 71.73 NASAL CONGESTION | 3 0.03 71.76 NASAL DISCOMFORT | 1 0.01 71.77 NASAL SINUS CANCER | 3 0.03 71.80 NASOPHARYNGEAL CANCER | 1 0.01 71.81 NASOPHARYNGITIS | 16 0.16 71.97 NAUSEA | 29 0.29 72.26 NECK INJURY | 1 0.01 72.27 NECK PAIN | 4 0.04 72.31 NECROSIS | 1 0.01 72.32 NECROTISING FASCIITIS | 2 0.02 72.34 NEOPLASM | 2 0.02 72.36 NEOPLASM MALIGNANT | 27 0.27 72.63 NEPHROTIC SYNDROME | 3 0.03 72.66 NERVOUSNESS | 2 0.02 72.68 NEURALGIA | 8 0.08 72.76 NEUROBLASTOMA | 1 0.01 72.77 NEUROENDOCRINE CARCINOMA OF THE SKIN | 2 0.02 72.79 NEUROGENIC BLADDER | 5 0.05 72.84 NEUROPATHIC PAIN | 10 0.10 72.94 NEUROPATHY | 2 0.02 72.96 NEUROPATHY PERIPHERAL | 6 0.06 73.02 NEUROSIS | 2 0.02 73.04 NEUTROPENIA | 5 0.05 73.09 NEUTROPHIL COUNT DECREASED | 1 0.01 73.10 NIGHT SWEATS | 1 0.01 73.11 NON-HODGKIN'S LYMPHOMA | 178 1.78 74.89 NON-SMALL CELL LUNG CANCER | 117 1.17 76.06 NON-SMALL CELL LUNG CANCER STAGE III | 8 0.08 76.14 NON-SMALL CELL LUNG CANCER STAGE IIIB | 4 0.04 76.18 NON-SMALL CELL LUNG CANCER STAGE IV | 2 0.02 76.20 NUCLEAR MAGNETIC RESONANCE IMAGING | 1 0.01 76.21 NUTRITIONAL SUPPORT | 2 0.02 76.23 OBESITY | 11 0.11 76.34 OBSESSIVE-COMPULSIVE DISORDER | 4 0.04 76.38 OEDEMA | 4 0.04 76.42 OEDEMA PERIPHERAL | 6 0.06 76.48 OESOPHAGEAL CANCER METASTATIC | 8 0.08 76.56 OESOPHAGEAL CANDIDIASIS | 1 0.01 76.57 OESOPHAGEAL CARCINOMA | 16 0.16 76.73 OESOPHAGEAL DISCOMFORT | 1 0.01 76.74 OESOPHAGEAL DISORDER | 3 0.03 76.77 OESOPHAGITIS | 2 0.02 76.79 OESTROGEN REPLACEMENT THERAPY | 2 0.02 76.81 OFF LABEL USE | 1 0.01 76.82 ONYCHOMYCOSIS | 14 0.14 76.96 OPEN ANGLE GLAUCOMA | 1 0.01 76.97 OPERATIVE HAEMORRHAGE | 3 0.03 77.00 ORAL CANDIDIASIS | 1 0.01 77.01 ORAL CONTRACEPTION | 6 0.06 77.07 ORGAN TRANSPLANT | 3 0.03 77.10 OROPHARYNGEAL CANCER STAGE UNSPECIFIED | 2 0.02 77.12 ORTHOSTATIC HYPOTENSION | 1 0.01 77.13 OSTEOARTHRITIS | 62 0.62 77.75 OSTEOLYSIS | 2 0.02 77.77 OSTEOMYELITIS | 4 0.04 77.81 OSTEOPENIA | 4 0.04 77.85 OSTEOPOROSIS | 109 1.09 78.94 OSTEOPOROSIS POSTMENOPAUSAL | 10 0.10 79.04 OSTEOPOROSIS PROPHYLAXIS | 10 0.10 79.14 OSTEOPOROTIC FRACTURE | 3 0.03 79.17 OTITIS MEDIA | 1 0.01 79.18 OTITIS MEDIA ACUTE | 1 0.01 79.19 OVARIAN CANCER | 21 0.21 79.40 OVARIAN CANCER METASTATIC | 1 0.01 79.41 OVERDOSE | 1 0.01 79.42 PAIN | 179 1.79 81.21 PAIN IN EXTREMITY | 4 0.04 81.25 PAIN IN JAW | 2 0.02 81.27 PAIN MANAGEMENT | 6 0.06 81.33 PALPITATIONS | 1 0.01 81.34 PANCREAS TRANSPLANT REJECTION | 1 0.01 81.35 PANCREATIC CARCINOMA | 27 0.27 81.62 PANCREATIC CARCINOMA METASTATIC | 5 0.05 81.67 PANCREATIC CARCINOMA STAGE IV | 1 0.01 81.68 PANCREATIC NECROSIS | 1 0.01 81.69 PANCREATITIS ACUTE | 1 0.01 81.70 PANCREATITIS CHRONIC | 1 0.01 81.71 PANIC ATTACK | 10 0.10 81.81 PANIC DISORDER | 3 0.03 81.84 PANIC REACTION | 1 0.01 81.85 PARENTERAL NUTRITION | 1 0.01 81.86 PARKINSON'S DISEASE | 35 0.35 82.21 PARKINSONISM | 2 0.02 82.23 PARTIAL SEIZURES | 1 0.01 82.24 PATENT DUCTUS ARTERIOSUS | 1 0.01 82.25 PATHOLOGICAL FRACTURE | 1 0.01 82.26 PENILE INFECTION | 1 0.01 82.27 PENIS CARCINOMA | 1 0.01 82.28 PEPTIC ULCER | 2 0.02 82.30 PERICORONITIS | 3 0.03 82.33 PERIPHERAL BLOOD STEM CELL APHERESIS | 1 0.01 82.34 PERIPHERAL OCCLUSIVE DISEASE | 3 0.03 82.37 PERITONEAL CARCINOMA | 4 0.04 82.41 PERITONEAL DIALYSIS | 3 0.03 82.44 PERNICIOUS ANAEMIA | 1 0.01 82.45 PERSECUTORY DELUSION | 1 0.01 82.46 PERSONALITY DISORDER | 2 0.02 82.48 PETIT MAL EPILEPSY | 1 0.01 82.49 PHANTOM PAIN | 1 0.01 82.50 PHARYNGEAL CANCER STAGE UNSPECIFIED | 3 0.03 82.53 PHARYNGITIS | 3 0.03 82.56 PHARYNGITIS STREPTOCOCCAL | 2 0.02 82.58 PHARYNGOLARYNGEAL PAIN | 1 0.01 82.59 PHLEBITIS | 1 0.01 82.60 PITUITARY TUMOUR | 1 0.01 82.61 PITUITARY TUMOUR BENIGN | 1 0.01 82.62 PLASMACYTOMA | 5 0.05 82.67 PLEURISY | 3 0.03 82.70 PNEUMOCYSTIS JIROVECI PNEUMONIA | 3 0.03 82.73 PNEUMONIA | 42 0.42 83.15 PNEUMONIA BACTERIAL | 4 0.04 83.19 POLYARTHRITIS | 11 0.11 83.30 POLYCYSTIC OVARIES | 5 0.05 83.35 POLYMYALGIA | 1 0.01 83.36 POLYMYALGIA RHEUMATICA | 1 0.01 83.37 POLYMYOSITIS | 1 0.01 83.38 POLYNEUROPATHY | 1 0.01 83.39 POLYURIA | 2 0.02 83.41 POOR PERIPHERAL CIRCULATION | 2 0.02 83.43 POST PROCEDURAL NAUSEA | 3 0.03 83.46 POST PROCEDURAL VOMITING | 2 0.02 83.48 POST-TRAUMATIC EPILEPSY | 3 0.03 83.51 POST-TRAUMATIC STRESS DISORDER | 7 0.07 83.58 POSTMENOPAUSE | 1 0.01 83.59 POSTOPERATIVE ANALGESIA | 5 0.05 83.64 POSTOPERATIVE CARE | 2 0.02 83.66 POSTOPERATIVE FEVER | 1 0.01 83.67 POSTOPERATIVE INFECTION | 2 0.02 83.69 POSTPARTUM DEPRESSION | 1 0.01 83.70 PRADER-WILLI SYNDROME | 1 0.01 83.71 PRECOCIOUS PUBERTY | 1 0.01 83.72 PREGNANCY | 1 0.01 83.73 PREMATURE EJACULATION | 1 0.01 83.74 PREMATURE LABOUR | 2 0.02 83.76 PREMATURE RUPTURE OF MEMBRANES | 1 0.01 83.77 PREMEDICATION | 21 0.21 83.98 PREOPERATIVE CARE | 4 0.04 84.02 PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS | 1 0.01 84.03 PROCEDURAL PAIN | 5 0.05 84.08 PRODUCTIVE COUGH | 1 0.01 84.09 PROGRESSIVE SUPRANUCLEAR PALSY | 1 0.01 84.10 PROLYMPHOCYTIC LEUKAEMIA | 1 0.01 84.11 PROPHYLACTIC CHEMOTHERAPY | 6 0.06 84.17 PROPHYLAXIS | 96 0.96 85.13 PROPHYLAXIS AGAINST DIARRHOEA | 2 0.02 85.15 PROPHYLAXIS AGAINST GASTROINTESTINAL .. | 13 0.13 85.28 PROPHYLAXIS AGAINST HIV INFECTION | 2 0.02 85.30 PROPHYLAXIS AGAINST MOTION SICKNESS | 1 0.01 85.31 PROPHYLAXIS AGAINST SOLAR RADIATION | 1 0.01 85.32 PROPHYLAXIS AGAINST TRANSPLANT REJECT.. | 50 0.50 85.82 PROPHYLAXIS OF NAUSEA AND VOMITING | 5 0.05 85.87 PROSTATE CANCER | 36 0.36 86.23 PROSTATE CANCER METASTATIC | 9 0.09 86.32 PROSTATE INFECTION | 1 0.01 86.33 PROSTATITIS | 9 0.09 86.42 PROSTHESIS USER | 1 0.01 86.43 PROTEUS INFECTION | 2 0.02 86.45 PRURITUS | 7 0.07 86.52 PSEUDOMONAS INFECTION | 4 0.04 86.56 PSEUDONEUROLOGIC SYMPTOM | 1 0.01 86.57 PSORIASIS | 25 0.25 86.82 PSORIATIC ARTHROPATHY | 6 0.06 86.88 PSYCHIATRIC SYMPTOM | 2 0.02 86.90 PSYCHOTIC DISORDER | 14 0.14 87.04 PULMONARY COCCIDIOIDES | 1 0.01 87.05 PULMONARY EMBOLISM | 3 0.03 87.08 PULMONARY FIBROSIS | 1 0.01 87.09 PULMONARY HYPERTENSION | 14 0.14 87.23 PULMONARY TUBERCULOSIS | 17 0.17 87.40 PUSTULAR PSORIASIS | 1 0.01 87.41 PYELONEPHRITIS | 2 0.02 87.43 PYREXIA | 29 0.29 87.72 QUADRIPLEGIA | 1 0.01 87.73 RADICULOPATHY | 1 0.01 87.74 RASH | 8 0.08 87.82 RASH PAPULAR | 1 0.01 87.83 RAYNAUD'S PHENOMENON | 1 0.01 87.84 RECTAL CANCER | 4 0.04 87.88 RECTAL CANCER METASTATIC | 2 0.02 87.90 REFLUX GASTRITIS | 1 0.01 87.91 REFLUX OESOPHAGITIS | 6 0.06 87.97 RELAPSING-REMITTING MULTIPLE SCLEROSIS | 9 0.09 88.06 RENAL CELL CARCINOMA STAGE UNSPECIFIED | 8 0.08 88.14 RENAL DISORDER | 1 0.01 88.15 RENAL FAILURE | 2 0.02 88.17 RENAL FAILURE ACUTE | 1 0.01 88.18 RENAL FAILURE CHRONIC | 16 0.16 88.34 RENAL IMPAIRMENT | 1 0.01 88.35 RENAL TRANSPLANT | 45 0.45 88.80 RESPIRATORY DISORDER | 14 0.14 88.94 RESPIRATORY SYNCYTIAL VIRUS INFECTION | 1 0.01 88.95 RESPIRATORY TRACT CONGESTION | 2 0.02 88.97 RESPIRATORY TRACT INFECTION | 2 0.02 88.99 RESPIRATORY TRACT INFECTION BACTERIAL | 3 0.03 89.02 RESTLESS LEGS SYNDROME | 2 0.02 89.04 RESTLESSNESS | 4 0.04 89.08 RETCHING | 1 0.01 89.09 RETINAL HAEMORRHAGE | 2 0.02 89.11 RHEUMATOID ARTHRITIS | 405 4.05 93.16 RHINITIS | 4 0.04 93.20 RHINITIS ALLERGIC | 11 0.11 93.31 RICKETS | 1 0.01 93.32 ROAD TRAFFIC ACCIDENT | 1 0.01 93.33 ROSACEA | 5 0.05 93.38 ROTATOR CUFF SYNDROME | 1 0.01 93.39 ROUTINE HEALTH MAINTENANCE | 1 0.01 93.40 SACRAL PAIN | 8 0.08 93.48 SALIVARY HYPERSECRETION | 1 0.01 93.49 SAPHO SYNDROME | 1 0.01 93.50 SCAN BRAIN | 3 0.03 93.53 SCAN WITH CONTRAST | 1 0.01 93.54 SCHIZOAFFECTIVE DISORDER | 19 0.19 93.73 SCHIZOPHRENIA | 59 0.59 94.32 SCHIZOPHRENIA, CATATONIC TYPE | 1 0.01 94.33 SCHIZOPHRENIA, PARANOID TYPE | 6 0.06 94.39 SCHIZOPHRENIA, UNDIFFERENTIATED TYPE | 1 0.01 94.40 SCHIZOPHRENIFORM DISORDER | 2 0.02 94.42 SCIATICA | 10 0.10 94.52 SCLERODERMA RENAL CRISIS | 1 0.01 94.53 SEASONAL ALLERGY | 11 0.11 94.64 SECONDARY HYPERTENSION | 1 0.01 94.65 SECONDARY PROGRESSIVE MULTIPLE SCLERO.. | 4 0.04 94.69 SEDATION | 13 0.13 94.82 SELF INJURIOUS BEHAVIOUR | 1 0.01 94.83 SENSITIVITY OF TEETH | 1 0.01 94.84 SENSORY DISTURBANCE | 1 0.01 94.85 SEPSIS | 6 0.06 94.91 SHOULDER PAIN | 7 0.07 94.98 SIMPLE PARTIAL SEIZURES | 2 0.02 95.00 SINUS CONGESTION | 2 0.02 95.02 SINUS DISORDER | 4 0.04 95.06 SINUSITIS | 14 0.14 95.20 SKIN DISORDER | 1 0.01 95.21 SKIN IRRITATION | 2 0.02 95.23 SKIN TIGHTNESS | 1 0.01 95.24 SKIN ULCER | 5 0.05 95.29 SKIN WRINKLING | 14 0.14 95.43 SLEEP DISORDER | 23 0.23 95.66 SLEEP DISORDER THERAPY | 13 0.13 95.79 SMALL CELL LUNG CANCER STAGE UNSPECIF.. | 13 0.13 95.92 SMOKING CESSATION THERAPY | 10 0.10 96.02 SNORING | 2 0.02 96.04 SOCIAL PHOBIA | 3 0.03 96.07 SOMNOLENCE | 1 0.01 96.08 SPINAL ANAESTHESIA | 2 0.02 96.10 SPINAL COLUMN STENOSIS | 2 0.02 96.12 SPINAL FRACTURE | 1 0.01 96.13 SPINAL OSTEOARTHRITIS | 5 0.05 96.18 SPONDYLITIS | 2 0.02 96.20 SQUAMOUS CELL CARCINOMA | 18 0.18 96.38 STAPHYLOCOCCAL INFECTION | 9 0.09 96.47 STEM CELL TRANSPLANT | 11 0.11 96.58 STENT PLACEMENT | 9 0.09 96.67 STERILISATION | 2 0.02 96.69 STOMACH DISCOMFORT | 4 0.04 96.73 STREPTOCOCCAL INFECTION | 2 0.02 96.75 STRESS | 2 0.02 96.77 STRESS ECHOCARDIOGRAM | 1 0.01 96.78 STRONGYLOIDIASIS | 2 0.02 96.80 SUICIDAL IDEATION | 1 0.01 96.81 SUICIDE ATTEMPT | 7 0.07 96.88 SUPERINFECTION LUNG | 9 0.09 96.97 SUPPRESSED LACTATION | 1 0.01 96.98 SUPRAVENTRICULAR TACHYCARDIA | 3 0.03 97.01 SURGERY | 4 0.04 97.05 SWELLING | 1 0.01 97.06 SWELLING FACE | 1 0.01 97.07 SYNCOPE | 1 0.01 97.08 SYNOVIAL SARCOMA | 3 0.03 97.11 SYSTEMIC ANTIVIRAL TREATMENT | 3 0.03 97.14 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME | 3 0.03 97.17 SYSTEMIC LUPUS ERYTHEMATOSUS | 7 0.07 97.24 SYSTEMIC MYCOSIS | 4 0.04 97.28 T-CELL CHRONIC LYMPHOCYTIC LEUKAEMIA | 2 0.02 97.30 TACHYARRHYTHMIA | 1 0.01 97.31 TACHYCARDIA | 2 0.02 97.33 TACHYCARDIA PAROXYSMAL | 1 0.01 97.34 TAY-SACHS DISEASE | 1 0.01 97.35 TEMPORAL LOBE EPILEPSY | 3 0.03 97.38 TENDON DISORDER | 1 0.01 97.39 TENDONITIS | 9 0.09 97.48 TENSION | 1 0.01 97.49 TESTIS CANCER | 3 0.03 97.52 THERAPEUTIC RESPONSE DECREASED | 1 0.01 97.53 THINKING ABNORMAL | 2 0.02 97.55 THROMBOCYTOPENIA | 1 0.01 97.56 THROMBOSIS | 5 0.05 97.61 THROMBOSIS PROPHYLAXIS | 17 0.17 97.78 THYMOMA | 3 0.03 97.81 THYROID DISORDER | 3 0.03 97.84 THYROID OPERATION | 1 0.01 97.85 THYROIDECTOMY | 2 0.02 97.87 TINEA PEDIS | 2 0.02 97.89 TINNITUS | 1 0.01 97.90 TOCOLYSIS | 2 0.02 97.92 TONGUE BLACK HAIRY | 1 0.01 97.93 TONSILLITIS | 1 0.01 97.94 TOOTH ABSCESS | 3 0.03 97.97 TOOTH INFECTION | 2 0.02 97.99 TOOTHACHE | 3 0.03 98.02 TORTICOLLIS | 3 0.03 98.05 TOXIC SKIN ERUPTION | 1 0.01 98.06 TOXOPLASMOSIS | 1 0.01 98.07 TRACHEOSTOMY | 1 0.01 98.08 TRANSITIONAL CELL CARCINOMA | 3 0.03 98.11 TRANSPLANT | 1 0.01 98.12 TRANSPLANT REJECTION | 7 0.07 98.19 TRANSURETHRAL PROSTATECTOMY | 1 0.01 98.20 TRAUMATIC HAEMORRHAGE | 4 0.04 98.24 TREMOR | 5 0.05 98.29 TRICHOSPORON INFECTION | 1 0.01 98.30 TRIGEMINAL NEURALGIA | 2 0.02 98.32 TUBERCULIN TEST | 2 0.02 98.34 TUBERCULOSIS | 14 0.14 98.48 TUBERCULOSIS PROPHYLAXIS | 7 0.07 98.55 TUBERCULOUS PLEURISY | 4 0.04 98.59 TUMOUR LYSIS SYNDROME | 1 0.01 98.60 TYPE IIA HYPERLIPIDAEMIA | 1 0.01 98.61 ULCER | 2 0.02 98.63 UNEVALUABLE EVENT | 6 0.06 98.69 UPPER LIMB FRACTURE | 1 0.01 98.70 UPPER RESPIRATORY TRACT INFECTION | 3 0.03 98.73 UPPER RESPIRATORY TRACT INFLAMMATION | 13 0.13 98.86 URGE INCONTINENCE | 1 0.01 98.87 URINARY BLADDER POLYP | 1 0.01 98.88 URINARY INCONTINENCE | 8 0.08 98.96 URINARY RETENTION | 2 0.02 98.98 URINARY TRACT DISORDER | 1 0.01 98.99 URINARY TRACT INFECTION | 22 0.22 99.21 URINE OUTPUT DECREASED | 1 0.01 99.22 URTICARIA | 7 0.07 99.29 URTICARIA CHRONIC | 1 0.01 99.30 UTERINE LEIOMYOMA | 4 0.04 99.34 UVEITIS | 1 0.01 99.35 VAGOTOMY | 1 0.01 99.36 VARICES OESOPHAGEAL | 1 0.01 99.37 VARICOSE VEIN | 2 0.02 99.39 VASCULAR DEMENTIA | 3 0.03 99.42 VASCULAR SHUNT | 1 0.01 99.43 VASCULITIS | 4 0.04 99.47 VENTRICULAR TACHYCARDIA | 2 0.02 99.49 VERTEBRAL INJURY | 2 0.02 99.51 VERTICAL INFECTION TRANSMISSION | 6 0.06 99.57 VERTIGO | 2 0.02 99.59 VIRAL INFECTION | 5 0.05 99.64 VIRAL LABYRINTHITIS | 1 0.01 99.65 VITAMIN B COMPLEX DEFICIENCY | 1 0.01 99.66 VITAMIN B12 DEFICIENCY | 1 0.01 99.67 VITAMIN SUPPLEMENTATION | 5 0.05 99.72 VOMITING | 9 0.09 99.81 VULVOVAGINAL DRYNESS | 1 0.01 99.82 WALDENSTROM'S MACROGLOBULINAEMIA | 1 0.01 99.83 WEIGHT CONTROL | 6 0.06 99.89 WEIGHT DECREASED | 3 0.03 99.92 WHITE BLOOD CELL COUNT DECREASED | 1 0.01 99.93 WOUND INFECTION | 6 0.06 99.99 WOUND INFECTION STAPHYLOCOCCAL | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015